Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective

by 24USATVNov. 17, 2020, midnight 59
-

Stéphane Bancel, the chief executive of Moderna, said in a statement that the results had provided “the first clinical validation that our vaccine can prevent Covid-19 disease, including severe disease.”

But the companies announced the findings in news releases, not in peer-reviewed scientific journals, and did not disclose the detailed data that would allow outside experts to evaluate their claims. Therefore, the results cannot be considered conclusive. The figures on effectiveness may change as the studies continue.

The companies’ products open the door to an entirely new way of creating vaccines — and creating them fast. Both use a synthetic version of coronavirus genetic material, called messenger RNA or mRNA, to program a person’s cells to churn out many copies of a fragment of the virus. That fragment sets off alarms in the immune system and stimulates it to attack, should the real virus try to invade. Although a number of vaccines using this technology are in development for other infections and cancers, none have yet been approved or marketed.

“The fact that two different vaccines made by two different companies with two different kinds of structures, in a new messenger RNA concept, both worked so effectively confirms the concept once and for all that this is a viable strategy not only for Covid but for future infectious disease threats,” said Dr. Barry R. Bloom, a professor of public health at Harvard.

Natalie E. Dean, a biostatistician at the University of Florida, said an important finding was that the vaccine appeared to prevent severe forms of the disease. Pfizer did not release information about disease severity when reporting its results.

Researchers say the positive results from Pfizer and Moderna bode well for other vaccines, because all of the candidates being tested aim at the same target — the so-called spike protein on the coronavirus that it uses to invade human cells.

Dr. Bloom said that the success of the two vaccines meant that measures of immunity used in earlier phases of the studies — participants’ antibody levels — were reliable, and that other companies could use those measures as proof of effectiveness to shorten the testing and approval process for their vaccines.

-

Related Articles

HOT TRENDS

MLB Opening Day: Listen to the New York Yankees vs. the Houston Astros

by 24USATVMarch 28, 2024, 9:20 p.m.2
HOT TRENDS

What we think we know about the 2024 Boston Red Sox on Opening Day

by 24USATVMarch 28, 2024, 9:20 p.m.2
HOT TRENDS

Matt’s Take – Cincinnati Reds Opening Day 2024

by 24USATVMarch 28, 2024, 8:20 p.m.2
HOT TRENDS

Reflections on the cusp of the Cubs’ 2024 season

by 24USATVMarch 28, 2024, 8:20 p.m.2
HOT TRENDS

Detroit Tigers' starting lineup for MLB Opening Day 2024 game announced

by 24USATVMarch 28, 2024, 8:20 p.m.2
HOT TRENDS

Yanks put Cole on 60-day IL due to injured elbow

by 24USATVMarch 28, 2024, 8:20 p.m.2
HOT TRENDS

Bishop Caggiano’s Homily for Holy Thursday Chrism Mass

by 24USATVMarch 28, 2024, 8:20 p.m.2
HOT TRENDS

Rebel Wilson Is in Her Taylor Swift ‘Reputation’ Era With New Selfie

by 24USATVMarch 28, 2024, 8:20 p.m.2
HOT TRENDS

Source: Chiefs to sign rugby star Rees-Zammit

by 24USATVMarch 28, 2024, 8:20 p.m.2
HOT TRENDS

Dogecoin Bets Jump to $2B as Price Reaches Highest Level Since 2021

by 24USATVMarch 28, 2024, 7:01 p.m.2
HOT TRENDS

True Story Behind We Were The Lucky Ones

by 24USATVMarch 28, 2024, 7:01 p.m.2
HOT TRENDS

Italy honors mafia victims in Holy Thursday Mass

by 24USATVMarch 28, 2024, 6:01 p.m.2
HOT TRENDS

Source: Chiefs to sign rugby star Rees-Zammit

by 24USATVMarch 28, 2024, 6:01 p.m.2
HOT TRENDS

A closer look: can right whales and offshore wind safely coexist?

by 24USATVMarch 28, 2024, 4 p.m.2
HOT TRENDS

No Eclipse Plans? Try These Last-Minute Strategies.

by 24USATVMarch 28, 2024, 2 p.m.2